Navy General Hospital, Beijing
Clinical trials sponsored by Navy General Hospital, Beijing, explained in plain language.
-
Smartwatches may help doctors decide when to treat AF, new trial aims to prove it
Disease control Not yet recruitingThis trial will enroll about 3,200 people with paroxysmal atrial fibrillation (AF) to see if using a smartwatch to continuously track AF burden can guide earlier and better treatment. Participants will be monitored with a wearable device, and if their AF burden is high, doctors w…
Phase: NA • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for Hard-to-Treat lymphoma: drug cocktail shows promise
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs (glofitamab, polatuzumab vedotin, and chemotherapy) in 80 adults with aggressive B-cell lymphoma that has come back or not responded to treatment. The goal is to see if this cocktail can shrink tumors and improve survival. The…
Phase: PHASE2 • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
10,000 AF patients tracked to find stroke threshold
Knowledge-focused Not yet recruitingThis observational study will follow 10,000 people with atrial fibrillation for 24 months. Researchers will use smartwatch data to measure how much time the heart is in AF (AF burden) and see if that predicts strokes or blood clots. The goal is to find a clear threshold where blo…
Sponsor: Navy General Hospital, Beijing • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC